Tapas Mazumder

Array ( [id] => 6266369 [patent_doc_number] => 20100298201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/625533 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 26458 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298201.pdf [firstpage_image] =>[orig_patent_app_number] => 12625533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794165 [patent_doc_number] => 09403916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Polysaccharide-and polypeptide-based block copolymers, vesicles constituted by these copolymers and use thereof' [patent_app_type] => utility [patent_app_number] => 13/126589 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 9230 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175728 [patent_doc_number] => 20110177491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'PEPTIDE FOR USE IN SIMULTANEOUS PROTEIN QUANTIFICATION OF METABOLIZING ENZYMES USING MASS SPECTROMETRIC ANALYSIS APPARATUS' [patent_app_type] => utility [patent_app_number] => 13/120705 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10349 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177491.pdf [firstpage_image] =>[orig_patent_app_number] => 13120705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580254 [patent_doc_number] => 20110294137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Sensor' [patent_app_type] => utility [patent_app_number] => 13/119112 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28552 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294137.pdf [firstpage_image] =>[orig_patent_app_number] => 13119112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490089 [patent_doc_number] => 20110237499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'HYBRID TRIPYRROLE-OCTAARGININE COMPOUNDS AND THEIR USE AS MEDICAMENT IN THE TREATMENT OF CANCER AND MICROBIAL ILLNESSES' [patent_app_type] => utility [patent_app_number] => 13/119954 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4137 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237499.pdf [firstpage_image] =>[orig_patent_app_number] => 13119954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113021 [patent_doc_number] => 20110190220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia' [patent_app_type] => utility [patent_app_number] => 13/054034 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7533 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190220.pdf [firstpage_image] =>[orig_patent_app_number] => 13054034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10586566 [patent_doc_number] => 09308162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Biocompatible oligomer-polymer compositions' [patent_app_type] => utility [patent_app_number] => 12/995910 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25961 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972478 [patent_doc_number] => 20110152176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'AGR-MEDIATED INHIBITION AND DISPERSAL OF BIOFILMS' [patent_app_type] => utility [patent_app_number] => 12/999038 [patent_app_country] => US [patent_app_date] => 2009-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18292 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152176.pdf [firstpage_image] =>[orig_patent_app_number] => 12999038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187019 [patent_doc_number] => 20110124843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHOD FOR EFFICIENTLY AMPLIFYING ABNORMAL PRION PROTEIN DERIVED FROM BSE' [patent_app_type] => utility [patent_app_number] => 12/994589 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6692 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124843.pdf [firstpage_image] =>[orig_patent_app_number] => 12994589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500505 [patent_doc_number] => 20110262991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications' [patent_app_type] => utility [patent_app_number] => 12/992854 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19301 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262991.pdf [firstpage_image] =>[orig_patent_app_number] => 12992854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8939442 [patent_doc_number] => 20130189239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Conjugated Factor VIII Molecules' [patent_app_type] => utility [patent_app_number] => 12/597473 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10579 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6162989 [patent_doc_number] => 20110160146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance' [patent_app_type] => utility [patent_app_number] => 12/865692 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17502 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160146.pdf [firstpage_image] =>[orig_patent_app_number] => 12865692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791559 [patent_doc_number] => 20120053115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Lantibiotic Carboxyamide Derivatives With Enhanced Antibacterial Activity' [patent_app_type] => utility [patent_app_number] => 13/130720 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11614 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053115.pdf [firstpage_image] =>[orig_patent_app_number] => 13130720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916786 [patent_doc_number] => 20130178412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'DIHYDROXYPROPLY-CYSTEINE PEPTIDE AND AGENT CONTAINING THIS PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/211561 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1094 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12211561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831321 [patent_doc_number] => 08859490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Peptide nucleic acid monomers and oligomers' [patent_app_type] => utility [patent_app_number] => 13/062194 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 17879 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831321 [patent_doc_number] => 08859490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Peptide nucleic acid monomers and oligomers' [patent_app_type] => utility [patent_app_number] => 13/062194 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 17879 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853421 [patent_doc_number] => 20080319164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'SYNTHESIS AND APPLICATION OF A FAMILY OF NEW MATERIALS RESULTING FROM THE CHEMICAL CROSS-LINKING BETWEEN GELATINE AND ORGANIC SALTS' [patent_app_type] => utility [patent_app_number] => 12/142960 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5174 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319164.pdf [firstpage_image] =>[orig_patent_app_number] => 12142960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711073 [patent_doc_number] => 20080299599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'FLUORESCENT PROTEINS FOR MONITORING INTRACELLULAR SUPEROXIDE PRODUCTION' [patent_app_type] => utility [patent_app_number] => 11/851148 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9404 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299599.pdf [firstpage_image] =>[orig_patent_app_number] => 11851148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922747 [patent_doc_number] => 20080071064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'TEMPERING' [patent_app_type] => utility [patent_app_number] => 11/766925 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12381 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20080071064.pdf [firstpage_image] =>[orig_patent_app_number] => 11766925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018594 [patent_doc_number] => 09061064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Implantable devices for chemonucleolysis of intervertebral discs' [patent_app_type] => utility [patent_app_number] => 11/605815 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 40 [patent_no_of_words] => 9252 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11605815 [rel_patent_id] =>[rel_patent_doc_number] =>)